Hence, individual MNs within an ALS patient can be categorized into two groups: early stage MNs (adequate nuclear TDP-43 expression; no cytoplasmic TDP-43 aggregation) and late stage MNs (lost nuclear TDP-43; cytoplasmic TDP-43 inclusions). This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.